Digital Patient Monitoring Devices Market to Surge with a 26.1% CAGR

Trishita Deb
Trishita Deb

Updated · May 14, 2024


At Media, we strive to bring you the most accurate and up-to-date information by utilizing a variety of resources, including paid and free sources, primary research, and phone interviews. Learn more.
Advertiser Disclosure

At Media, we strive to bring you the most accurate and up-to-date information by utilizing a variety of resources, including paid and free sources, primary research, and phone interviews. Our data is available to the public free of charge, and we encourage you to use it to inform your personal or business decisions. If you choose to republish our data on your own website, we simply ask that you provide a proper citation or link back to the respective page on Media. We appreciate your support and look forward to continuing to provide valuable insights for our audience.


The global Digital Patient Monitoring Devices Market is projected to expand significantly, with its value expected to surge from USD 144.3 billion in 2023 to USD 1467 billion by 2033, reflecting a robust compound annual growth rate (CAGR) of 26.1% during the forecast period from 2024 to 2033. This substantial growth can be attributed to several key factors.

Firstly, the rising prevalence of chronic diseases such as diabetes, cardiovascular diseases, and respiratory conditions necessitates continuous monitoring, thereby driving demand for digital patient monitoring devices. Advances in wearable technology, including smartwatches and fitness trackers, have facilitated the adoption of these devices for remote health monitoring, improving patient outcomes and reducing hospital visits​.

Moreover, the integration of artificial intelligence (AI) and machine learning in monitoring devices is enhancing the accuracy of health data analysis, leading to more personalized and proactive healthcare interventions. The COVID-19 pandemic has further accelerated the market’s growth by highlighting the importance of remote patient monitoring to prevent disease transmission and manage patient care effectively​.

However, the market faces challenges such as data privacy concerns and the high cost of advanced monitoring devices, which may hinder widespread adoption. Additionally, regulatory hurdles and the need for continuous technological advancements pose significant barriers to market growth​.

Recent developments include the introduction of AI-powered remote monitoring devices and increased government funding to support digital health initiatives. For instance, in 2022, Abbott received FDA clearance for the FreeStyle Libre 3 system, a compact glucose sensor, which exemplifies the ongoing innovation in the sector​.

Overall, the Digital Patient Monitoring Devices Market is poised for robust growth, driven by technological advancements, increasing chronic disease prevalence, and supportive government policies, despite facing certain challenges that need to be addressed.

Key Takeaways

  • In 2023, the global digital patient monitoring devices market earned USD 144.3 billion, expected to surpass USD 1467 billion by the forecast period’s end, growing at a CAGR of 26.1%.
  • The wearable devices segment led the market in 2023, holding a 33.6% market share based on device type.
  • Diagnostic patient monitoring devices dominated by product type, capturing a substantial 70.8% market share in 2023.
  • North America remained the dominant region, maintaining a market share of 41.9% in the global digital patient monitoring devices market.
Digital Patient Monitoring Devices Market Size
To learn more about this report – request a sample report PDF

Digital Patient Monitoring Devices Statistics

General Statics

  • Over 23 million patients used remote patient monitoring tools by 2020, expected to exceed 30 million by 2024.
  • Virtual visits rose from 14% in 2016 to 80% by 2022, while remote monitoring device usage doubled from 12% to 30%.
  • University of Pittsburgh Medical Center achieved over 90% patient satisfaction with remote monitoring.
  • Remote patient monitoring reduces hospital admissions by 38% and emergency room visits by 51%.
  • 88% of healthcare providers believe remote monitoring improves patient outcomes.
  • Remote monitoring can save up to USD 200 billion in healthcare costs over 25 years.
  • 29.1 million individuals in the US used remote patient monitoring in 2020, expected to reach 709.6 million by 2024.
  • RPM users report a 76% reduction in hospital readmissions, with 90% satisfaction.
  • RPM technology engagement rates reached 78.9% in 2021.
  • Wearable device usage in RPM is rising, with significant potential to reduce healthcare costs and improve patient care.

Wearable Devices in Remote Patient Monitoring

  • Regular Use by Women: Approximately 25% of women regularly use a specific healthcare device.
  • Overall Usage: About 30% (1266 out of 4551) of adults use wearable healthcare devices.
  • High Usage Among Women: Women are among the most likely groups to use wearable healthcare devices, at a rate of 16.25%.
  • Insurance Incentives: 69% of Americans would wear a smartwatch if it reduced their insurance premium; 46% are willing to share their data.
  • Physician Support: 88% of physicians want patients to monitor their health parameters at home.
  • Daily Dependence: Nearly 50% of users rely on wearable technology daily, with over 80% willing to share data with healthcare providers.
  • Growth in Wearables: The number of connected wearable devices increased from 325 million in 2016 to 722 million in 2019.
  • Market Expansion: The global market for medical wearable devices is booming, projected to grow from 275 million units in 2021 to nearly 440 million units in 2024.

Role of Telemedicine in Remote Patient Monitoring

  • A McKinsey report shows telehealth usage in the U.S. jumped from 11% in 2019 to 46% in 2020 during the COVID-19 pandemic.
  • The American Medical Association reported that 83% of U.S. doctors offered telehealth services in 2022, up from just 22% in 2019.
  • Remote Patient Monitoring (RPM) can significantly reduce healthcare costs, cutting them by 53%, saving approximately USD 8,375 per patient over six months, according to the Journal of Medical Economics.
  • projects the global telemedicine market to reach USD 590.9 billion by 2032, growing from USD 63.5 billion in 2022 at a CAGR of 25.7%.

Developments (Acquisitions, Mergers, New Product Launches, Funding)

  • HealthTech Solutions acquired RemoteCare Technologies for $200 million, expanding its remote patient monitoring solutions portfolio and enhancing telehealth services capabilities.
  • CareGuard introduced a wearable device for elderly patients, offering real-time vital signs tracking and fall detection, aiming to sell 100,000 units within the first year.
  • HealthTrack launched a mobile app for remote patient monitoring, enabling patients to upload health data and communicate with providers, targeting 500,000 downloads within six months.
  • RemoteCare received $50 million in Series A funding led by Healthcare Investment Group to scale their remote monitoring platform and invest in AI algorithms for data analysis, aiming for a 50% increase in patient enrollment within the next year.
  • TeleHealth secured $30 million in seed funding from Tech Investors to expand its telemedicine network and develop remote monitoring solutions for chronic disease management, targeting a 40% growth in user engagement.
  • Rising demand for home-based healthcare services fueled a 20% increase in sales of remote monitoring devices compared to the previous year.
  • Remote patient monitoring usage surged during the COVID-19 pandemic, with a 30% increase in telehealth visits and remote monitoring consultations, reflecting growing acceptance of virtual care solutions.

Emerging Trends

  • Advanced Wearable Technologies: Wearable devices now feature sensors measuring advanced biometrics such as oxygen saturation, skin temperature, and stress levels. These enhancements provide comprehensive patient data, facilitating improved health monitoring and management. By capturing a wide range of physiological metrics, these advanced wearables support better-informed clinical decisions and personalized care strategies.
  • AI and Machine Learning Integration: AI and machine learning are enhancing remote patient monitoring (RPM) systems’ predictive capabilities by analyzing vast amounts of patient data. These technologies predict health issues and offer personalized care recommendations, thereby significantly improving patient outcomes. The integration of AI and machine learning enables more accurate and timely interventions, supporting proactive health management.
  • Telehealth and RPM Convergence: The convergence of telehealth and RPM is creating integrated care models that improve the quality and efficiency of healthcare delivery. Real-time patient data is accessible during virtual consultations, enabling healthcare providers to make informed decisions and offer timely interventions. This integration streamlines care processes, enhancing the overall patient experience and outcomes.
  • Patient Engagement and Education: Patient engagement tools are advancing to include gamification, VR/AR for education, and AI-driven health nudges. These innovations increase patient adherence to treatment plans, crucial for managing chronic diseases. By making health management more interactive and personalized, these tools foster better patient involvement and improved health outcomes.
  • Enhanced Data Security: With the rise in RPM adoption, ensuring data security is critical. Advanced encryption and blockchain technology are being utilized to protect patient data and enable secure information exchange between healthcare systems. These measures ensure the confidentiality and integrity of sensitive health information, promoting trust and compliance in RPM practices.
  • Expansion in Chronic Disease Management: RPM is increasingly utilized in chronic disease management with condition-specific modules. For example, heart failure patients benefit from advanced fluid status monitoring, and diabetes management incorporates continuous glucose monitoring. These tailored RPM solutions provide targeted care, enhancing disease management and improving patient quality of life.
  • Insurance and Reimbursement Policies: There is a shift towards value-based care models, where insurance reimbursements are tied to patient outcomes and RPM efficiency. This trend encourages the adoption of advanced RPM systems that can demonstrate tangible improvements in health metrics. Value-based models incentivize healthcare providers to leverage RPM for better patient care and cost-effectiveness.

Use Cases

  • Chronic Disease Management: Remote patient monitoring (RPM) devices are crucial for managing chronic diseases like diabetes, hypertension, and heart failure. Devices such as continuous glucose monitors, blood pressure cuffs, and heart rate monitors track health metrics, enabling timely interventions and improved disease management. The global market for these devices is expected to reach $1.7 billion by 2027.
  • Post-Operative Care: RPM devices play a significant role in post-operative care by monitoring patients’ vital signs, thus reducing the need for extended hospital stays. Continuous monitoring helps detect complications early, facilitating faster recovery. The adoption of hospital-at-home programs, supported by RPM technologies, is anticipated to grow, providing hospital-level care at home.
  • Elderly Care: Wearable RPM devices for elderly care monitor vital signs and detect falls, ensuring timely assistance. CareGuard’s wearable device, aiming to sell 100,000 units in its first year, highlights the increasing demand for elderly care solutions. These devices enhance safety and health monitoring for senior citizens.
  • Telehealth Integration: RPM devices integrated with telehealth platforms enable real-time data sharing during virtual consultations, improving chronic condition management and reducing the need for in-person visits. This integration enhances healthcare accessibility, particularly for patients in remote areas, by providing continuous monitoring and better health management.
  • Cardiology and Oncology: In cardiology, RPM devices like cardiac patches monitor heart conditions such as atrial fibrillation, reducing stroke risks. In oncology, RPM helps track post-treatment symptoms, offering continuous monitoring for cancer patients and enhancing their quality of care. These devices provide critical data for managing and treating complex health conditions.


The digital patient monitoring devices market is set to experience significant growth, driven by technological advancements and the increasing prevalence of chronic diseases. Factors such as the integration of artificial intelligence, the rise in wearable devices, and the convergence of telehealth with remote patient monitoring are enhancing patient care and operational efficiency.

North America currently leads the market due to high adoption rates of advanced technologies and supportive government initiatives, while the Asia Pacific region is projected to grow rapidly. Despite challenges like data privacy concerns and high costs, the market is poised for robust expansion, offering promising opportunities for stakeholders in the healthcare sector.

Trishita Deb

Trishita Deb

Trishita has more than 7 years of experience in market research and consulting industry. She has worked in various domains including healthcare, consumer goods, and materials. Her expertise lies majorly in healthcare and has worked on more than 400 healthcare reports throughout her career.